DAX 25.123 +0,0%ESt50 6.277 -0,1%MSCI World 4.851 +0,8%Top 10 Crypto 8,41 +2,8%Nas 26.164 -0,2%Bitcoin 56.214 +1,6%Euro 1,1422 -0,1%Öl 76,2 +0,4%Gold 4.103 -0,5%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026

Werte in diesem Artikel
Aktien
Carl Zeiss Meditec AG
30.00 EUR 0.64 EUR 2.18 %
Charts | News | Analysen
Aktie kaufen

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026

08-Dec-2025 / 14:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung

Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 –
interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch
 
Jena, 8 December 2025
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) and Maximilian Foerst have mutually agreed to terminate Maximilian Foerst’s Executive Board mandate as of 31 December 2025.

The reason for this decision is a violation, acknowledged by Maximilian Foerst, of the ZEISS Group’s internal Code of Conduct in connection with a conflict of interest involving interactions with an individual within the ZEISS internal working environment, which dates back several years. The case is not related to the business activities of ZEISS Group or to the business of Carl Zeiss Meditec AG.

The Supervisory Board is working at full speed to identify a successor. On an interim basis, Andreas Pecher, currently Chairman of the Supervisory Board of Carl Zeiss Meditec AG and CEO of Carl Zeiss AG, will assume the role of CEO of Carl Zeiss Meditec AG as of 1 January 2026. He will resign from his Supervisory Board mandate beforehand. The Supervisory Board will be chaired on an interim basis by Peter Kameritsch.

Accordingly, as of 1 January 2026, the Executive Board of Carl Zeiss Meditec AG will consist of Andreas Pecher (Chief Executive Officer, ad interim) and Justus Felix Wehmer (Chief Financial Officer).

The successfully initiated strategic realignment under Maximilian Foerst will continue at an unchanged pace.
 
 

Contact for investors and press

Sebastian Frericks

Head of Group Finance & Investor Relations

Carl Zeiss Meditec AG

Tel.: +49 3641 220-116

E-Mail: investors.med@zeiss.com

Werbung

 

 

 

 

 

 

 

 

 



End of Inside Information

08-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2241862

 
End of Announcement EQS News Service
Werbung

2241862  08-Dec-2025 CET/CEST

Aktuelle Carl Zeiss Meditec Aktie News

Werbung

Carl Zeiss Meditec Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Carl Zeiss Meditec nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
07.07.26 Carl Zeiss Meditec Market-Perform Bernstein Research
14.05.26 Carl Zeiss Meditec Market-Perform Bernstein Research
14.05.26 Carl Zeiss Meditec Neutral Goldman Sachs Group Inc.
13.05.26 Carl Zeiss Meditec Hold Deutsche Bank AG
13.05.26 Carl Zeiss Meditec Equal Weight Barclays Capital